Chiome Bioscience Inc. (TYO:4583)
Japan flag Japan · Delayed Price · Currency is JPY
133.00
-5.00 (-3.62%)
Sep 10, 2025, 3:30 PM JST

Chiome Bioscience Revenue

Chiome Bioscience had revenue of 113.10M JPY in the quarter ending June 30, 2025, a decrease of -15.65%. This brings the company's revenue in the last twelve months to 768.88M, up 30.92% year-over-year. In the year 2024, Chiome Bioscience had annual revenue of 780.81M with 14.41% growth.

Revenue (ttm)
768.88M
Revenue Growth
+30.92%
P/S Ratio
11.77
Revenue / Employee
14.51M
Employees
53
Market Cap
9.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024780.81M98.35M14.41%
Dec 31, 2023682.46M51.65M8.19%
Dec 31, 2022630.82M-82.12M-11.52%
Dec 31, 2021712.93M232.08M48.26%
Dec 31, 2020480.85M33.28M7.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Mar 31, 2012 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,196.21B
Takeda Pharmaceutical Company4,480.25B
HOYA Corporation876.09B
Daiichi Sankyo Company1,924.68B
Otsuka Holdings2,401.70B
Terumo1,037.94B
Astellas Pharma1,944.99B
Shionogi &440.50B
Revenue Rankings